In conclusion, our data show for the first time that BCP has a marked efficacy in a preclinical in vitro model of oral mucositis: this effect, in light of its high translational potential, deserves to be confirmed in a clinical setting. The gene discussed is OPN1SW; the disease is oral mucositis.